We are live on ! Find out more
AHI

Advanced Health Intelligence Ltd

Delisted

AHI was delisted on the 31st of January, 2024.

11 hedge funds and large institutions have $161K invested in Advanced Health Intelligence Ltd in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

386% more capital invested

Capital invested by funds: $33.1K → $161K (+$128K)

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

120% more funds holding

Funds holding: 511 (+6)

Holders
11
Holders Change
+6
Holders Change %
+120%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
2
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AHI Hedge Fund Activity: Q3 2022 in Review

11 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Advanced Health Intelligence Ltd (AHI) for Q3 2022, worth a combined $161K — up 386% from $33.1K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AHI positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Old Mission Capital, opening a new position worth an estimated $46.7K. The largest seller was StoneX Group, exiting entirely with an estimated $19.1K sold.

  • 11 institutional investors held Advanced Health Intelligence Ltd (AHI) as of Q3 2022, up from 5 in Q2 2022.
  • Funds reported $161K of Advanced Health Intelligence Ltd stock for Q3 2022, up 386% quarter-over-quarter.
  • 8 funds opened new Advanced Health Intelligence Ltd positions in Q3 2022 and 2 closed out, a net change of +6 holders.
  • The largest Advanced Health Intelligence Ltd buyer in Q3 2022 was Old Mission Capital, an estimated $46.7K added.
  • The largest Advanced Health Intelligence Ltd seller in Q3 2022 was StoneX Group, an estimated $19.1K sold.

Based on aggregated 13F filings for Q3 2022.